Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginkgolic acid is a phenolic compound found in the leaves and seeds of Ginkgo biloba. It is structurally related to anacardic acids and exists in several forms depending on the length and saturation of its alkyl side chain; the most studied form is ginkgolic acid C17:1. Ginkgolic acids are known for their broad biological activities including neuroprotective, antimicrobial (notably against Gram-positive bacteria), antitumoral, anti-inflammatory, and antiviral effects. Mechanistically, ginkgolic acids act as multi-target inhibitors affecting key enzymes involved in pro-inflammatory lipid mediator biosynthesis such as cyclooxygenases (COX), lipoxygenases (LOX), and microsomal prostaglandin E synthase-1 (mPGES-1). They also inhibit protein SUMOylation by targeting SUMO-activating enzyme E1 and interfere with histone acetyltransferase activity. Additionally, they modulate signaling pathways such as STAT3 via induction of PTEN and SHP-1 tyrosine phosphatase[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginkgolic acid.